Market Cap : 1.79 B | Enterprise Value : 1.54 B | PE Ratio : | PB Ratio : 5.07 |
---|
NAS:TVTX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:TVTX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Travere Therapeutics's Notes Receivable for the quarter that ended in Sep. 2020 was $0.0 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.
No Headline